International Clinical Trial: A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients

Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533565) titled 'A Pilot Study of Mirabegron and Montelukast in Cirrhotic Patients' on April 10.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Kafrelsheikh University

Condition: Cirrhosis Asthma

Intervention: Drug: Mirabegron 100 mg Drug: Mirabegron 50mg Drug: Mirabegron 50mg Drug: mirabegron 25 mg Drug: Montelukast 10 mg Drug: montelukast (5mg QD)

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 1, 2024

Target Sample Size: 78

Countries of Recruitment:...